Clinical Trial Update: Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant FOLFOXIRI chemotherapy for patients with locally advanced colon cancer (colonic neoplasms).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer

Drugs mentioned

• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: China Medical University, China | Conditions: Colonic Neoplasms, Drug Therapy | Phase 2 | Status: UNKNOWN